Diversified Healthcare Trust
DHC
$2.50
-$0.02-0.79%
| Weiss Ratings | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E+ | |||
| Rating Factors | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.58 | |||
| Price History | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.09% | |||
| 30-Day Total Return | 4.60% | |||
| 60-Day Total Return | 0.46% | |||
| 90-Day Total Return | -30.04% | |||
| Year to Date Total Return | 10.64% | |||
| 1-Year Total Return | -4.23% | |||
| 2-Year Total Return | 76.64% | |||
| 3-Year Total Return | -9.06% | |||
| 5-Year Total Return | -20.98% | |||
| 52-Week High % Change | -41.04% | |||
| 52-Week Low % Change | 24.69% | |||
| Price | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.24 | |||
| 52-Week Low Price | $2.01 | |||
| 52-Week Low Price (Date) | Jan 13, 2025 | |||
| 52-Week High Price (Date) | Sep 30, 2024 | |||
| Valuation | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 603.18M | |||
| Enterprise Value | 3.39B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.55 | |||
| Earnings Per Share Growth | 25.78% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.40 | |||
| Price/Book (Q) | 0.31 | |||
| Enterprise Value/Revenue (TTM) | 2.27 | |||
| Price | $2.50 | |||
| Enterprise Value/EBITDA (TTM) | 14.74 | |||
| Enterprise Value/EBIT | -61.52 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 239.95M | |||
| Dividend Yield | 1.60% | |||
| Div. Per Share (Most Recent) | $0.01 | |||
| Dividend Per Share (TTM) | $0.04 | |||
| Payout Ratio (TTM) | -2.60% | |||
| Dividend Per Share (Most Recent) | $0.01 | |||
| Company Info | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 617 796 8350 | |||
| Address | Two Newton Place Newton, MA 02458-1634 | |||
| Website | www.dhcreit.com | |||
| Country | United States | |||
| Year Founded | 1998 | |||
| Profitability | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -3.68% | |||
| Profit Margin | -24.75% | |||
| Management Effectiveness | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.65% | |||
| Return on Equity | -- | |||
| Income Statement | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 251.04M | |||
| Total Revenue (TTM) | 1.50B | |||
| Revenue Per Share | $6.23 | |||
| Gross Profit (TTM) | 256.38M | |||
| EBITDA (TTM) | 229.96M | |||
| EBIT (TTM) | -55.10M | |||
| Net Income (TTM) | -370.26M | |||
| Net Income Avl. to Common (TTM) | -370.26M | |||
| Total Revenue Growth (Q YOY) | 5.00% | |||
| Earnings Growth (Q YOY) | 14.74% | |||
| EPS Diluted (TTM) | -1.55 | |||
| EPS Diluted Growth (Q YOY) | 15.02% | |||
| Balance Sheet | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 144.58M | |||
| Cash Per Share (Q) | $0.60 | |||
| Total Current Assets (Q) | 500.00M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.96B | |||
| Current Ratio (Q) | 17.173 | |||
| Book Value Per Share (Q) | $8.12 | |||
| Total Assets (Q) | 5.14B | |||
| Total Current Liabilities (Q) | 29.12M | |||
| Total Debt (Q) | 2.93B | |||
| Total Liabilities (Q) | 3.18B | |||
| Total Common Equity (Q) | 1.96B | |||
| Cash Flow | DHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -187.02M | |||
| Cash from Financing (TTM) | -22.31M | |||
| Net Change in Cash (TTM) | -97.11M | |||
| Levered Free Cash Flow (TTM) | -150.97M | |||
| Cash from Operations (TTM) | 112.22M | |||
